Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03392935 · ClinicalTrials.gov registry record · NA
Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas
A NA study of Dermatofibroma of Skin, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03392935 is a NA study of Dermatofibroma of Skin that has completed, run by University of Utah. The registered enrollment target is 37 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03392935, a NA study of Dermatofibroma of Skin, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to find a more effective treatment for itchy, painful or unsightly dermatofibromas, that will improve symptoms of itch and/or pain and/or improve the appearance of dermatofibromas. This is an open-label study where subjects will receive a laser treatment at week 0, and week 4, and then 2 additional follow-up visits. Photographs will be taken at each visit and rated by blinded reviewers after the study to determine efficacy.
Conditions Studied
Interventions
- DEVICE 1540 nanometer Erbium glass laser
Study Locations (1)
Utah
- University of Utah Dermatology - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-11-30 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03392935
The ClinicalTrials.gov registry entry for NCT03392935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermatofibroma of Skin appearing as the primary indexed condition, and to 1 intervention - of which 1540 nanometer Erbium glass laser is the first listed.
NCT03392935 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT03392935 about?
NCT03392935 is a clinical study titled "Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas". This study is to find a more effective treatment for itchy, painful or unsightly dermatofibromas, that will improve symptoms of itch and/or pain and/or improve the appearance of dermatofibromas. This is an open-label study where subjects will receive a laser treatment at week 0, and week 4, and then...
What is the current status of trial NCT03392935?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-11-30. Estimated completion is 2021-03-31.
What conditions does trial NCT03392935 study?
This clinical trial studies the following conditions: Dermatofibroma of Skin.
What interventions are being tested in trial NCT03392935?
The interventions under investigation include: 1540 nanometer Erbium glass laser (DEVICE).
Who is sponsoring clinical trial NCT03392935?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03392935 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.